Synthetic gastric-protein fragment studied in tissue, tendon, and gut-repair literature.
What it is
Synthetic gastric-protein fragment studied in tissue, tendon, and gut-repair literature.
Also known as
Body Protective Compound-157 · BPC 15 · Bepecin · PL 14736 (research names)
Overview
BPC-157 is a synthetic 15–amino-acid fragment derived from a gastric protein sequence and studied extensively in tissue, tendon, and gut-repair literature. Preclinical work spans musculoskeletal injury models, gastrointestinal mucosal assays, and angiogenesis-related readouts.
As a research reagent it is used to probe repair signaling across soft tissue, bone-adjacent, and enteric models—not as a clinical protocol. Left Turn Adventures supplies this compound for laboratory and research use only.
Proven benefits
Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.
Tendon, ligament, muscle, and bone repair endpoints in preclinical models
• Inflammation readouts in musculoskeletal research designs
• Angiogenesis markers in tissue-repair literature
• GI mucosal-protection endpoints in gut-injury models
• Nerve-injury recovery markers in preclinical neurorepair studies
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: Early tissue and inflammation readouts in acute injury or repair models; compound exposure establishing.
Week 3–4: Clearer repair, angiogenesis, and mobility-adjacent markers in short research windows.
Month 2–3: More pronounced tendon/ligament/soft-tissue endpoints in extended preclinical designs.
Month 3–6: Sustained remodeling and recovery-marker observations where studied longer.
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.